Sage Journals: Discover world-class research

Abstract

OBJECTIVE

The aim of the present study was to verify whether drugs injected into the endolymphatic sac (ES) can reach the cochlea and possibly treat inner ear disorders.

STUDY DESIGN

Prospective cohort study.

SETTING

Tertiary referral center, Otolaryngology Department, University of Verona.

SUBJECTS AND METHODS

Patients with Ménière's disease (MD) who were candidates for ES decompression were selected. Nineteen subjects received dexamethasone (DEX) via injection into the ES. To objectively define whether substances administered into the ES could reach the cochlea, we added gadolinium (GD) in three patients. All subjects had intraoperative electrocorticogram recordings and an audiologic follow-up. The three subjects who underwent injection of the DEX-GD solution were followed-up with magnetic resonance imaging. The audio-logical data are presented during a follow-up period of 12 months.

RESULTS

Intraoperative electrocochleography recordings revealed no changes in two patients and summating potentials and compound action potential latency and wave-form modifications in all the other subjects. GD distribution was observed from 48 hours to one week after ES injection into the cochlea of the three subjects injected with DEX-GD. GD-related enhancement of inner ear structures lasted more than two weeks in all subjects. Pure tone average results showed hearing improvement of at least 20 dB HL in 42 percent of patients (8 of 19) at the 12-month follow-up. Statistically significant differences emerged between the mean pure tone average of the ES procedure subjects at one and 12 months after surgery (P = 0.0096).

CONCLUSION

This novel approach might reveal new prospects for treating viral, metabolic, autoimmune, and genetic disorders of the cochlea.

Get full access to this article

View all access options for this article.

References

1 Hamid

Trune

. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008;16:434–40.

2 Sajjadi

Paparella

. Meniere's disease. Lancet 2008;372:406–14.

3 Juhn

Hunter

Odland

. Blood—labyrinth barrier and fluid dynamics of the inner ear. Int Tinnitus J 2001;7:72–83.

4 Swan

Mescher

Sewell

. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60:1583–99.

5 Hildebrand

Newton

Gubbels

. Advances in molecular and cellular therapies for hearing loss. Mol Ther 2008;16:224–36.

6 Beisel

Hansen

Soukup

. Regenerating cochlear hair cells: quo vadis stem cell. Cell Tissue Res 2008;333:373–9.

7 Izumikawa

Minoda

Kawamoto

. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005;11:271–6.

8 Kawamoto

Ishimoto

Minoda

. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003;23:4395–400.

9 Praetorius

Brough

Hsu

. Adenoviral vectors for improved gene delivery to the inner ear. Hear Res 2009;248:31–8.

10.

10 Yamasoba

Yagi

Roessler

. Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999;10:769–74.

11.

11 Kitahara

Kubo

Okumura

. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study. Laryngoscope 2008;118:854–61.

12.

12 Salt

Brown

Hartsock

. Displacements of the organ of Corti by gel injections into the cochlear apex. Hear Res 2009;250:63–75.

13.

13 Ikino

de Almeida

. Summating potential-action potential waveform amplitude and width in the diagnosis of Menière's disease. Laryngoscope 2006;116:1766–9.

14.

14 Ohashi

Nishino

Arai

. Clinical significance of the summating potential-action potential ratio and the action potential latency difference for condensation and rarefaction clicks in Meniere's disease. Ann Otol Rhinol Laryngol 2009;118:307–12.

15.

15 Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology—Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–5.

16.

16 Naganawa

Satake

Kawamura

. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 2008;18:920–4.

17.

17 Nakashima

Naganawa

Sugiura

. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415–20.

18.

18 Ahn

Yoo

Yoon

. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope 2008;118:279–82.

19.

19 Plontke

Lowenheim

Mertens

. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359–69.

20.

20 Plontke

Siedow

Wegener

. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol 2007;12:37–48.

21.

21 Kingma

Wit

. Acute endolymphatic hydrops has no direct effect on the vestibular evoked potential in the guinea pig. J Vestib Res 2009;19:27–32.

22.

22 Collado

Burns

. Recent advances in hair cell regeneration research. Curr Opin Otolaryngol Head Neck Surg 2008;16:465–71.

Induced endolymphatic flow from the endolymphatic sac to the cochlea in Ménière's disease